|
|
muscle cell development
|
GO:0055001 |
133 |
0.991
|
|
|
|
regulation of skeletal muscle contraction
|
GO:0014819 |
3 |
0.983
|
|
|
|
transition between fast and slow fiber
|
GO:0014883 |
9 |
0.980
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.958
|
|
|
|
skeletal muscle adaptation
|
GO:0043501 |
16 |
0.935
|
|
|
|
sarcomere organization
|
GO:0045214 |
24 |
0.935
|
|
|
|
striated muscle adaptation
|
GO:0014888 |
26 |
0.920
|
|
|
|
striated muscle myosin thick filament assembly
|
GO:0071688 |
1 |
0.913
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.904
|
|
|
|
muscle adaptation
|
GO:0043500 |
39 |
0.901
|
|
|
|
regulation of muscle adaptation
|
GO:0043502 |
31 |
0.899
|
|
|
|
regulation of heart contraction
|
GO:0008016 |
77 |
0.896
|
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
139 |
0.891
|
|
|
|
regulation of muscle system process
|
GO:0090257 |
80 |
0.879
|
|
|
|
regulation of skeletal muscle adaptation
|
GO:0014733 |
12 |
0.875
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.872
|
|
|
|
regulation of atp catabolic process
|
GO:1903289 |
9 |
0.867
|
|
|
|
actin filament based movement
|
GO:0030048 |
23 |
0.850
|
|
|
|
actomyosin structure organization
|
GO:0031032 |
56 |
0.848
|
|
|
|
release of sequestered calcium ion into cytosol by sarcoplasmic reticulum
|
GO:0014808 |
12 |
0.847
|
|
|
|
skeletal muscle fiber development
|
GO:0048741 |
58 |
0.813
|
|
|
|
striated muscle contraction
|
GO:0006941 |
45 |
0.810
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.802
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.799
|
|
|
|
myofibril assembly
|
GO:0030239 |
34 |
0.794
|
|
|
|
regulation of cardiac muscle contraction by calcium ion signaling
|
GO:0010882 |
9 |
0.789
|
|
|
|
myosin filament assembly
|
GO:0031034 |
2 |
0.765
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.762
|
|
|
|
myosin filament organization
|
GO:0031033 |
3 |
0.757
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.754
|
|
|
|
cardiac muscle cell development
|
GO:0055013 |
39 |
0.752
|
|
|
|
heart contraction
|
GO:0060047 |
93 |
0.717
|
|
|
|
regulation of atp metabolic process
|
GO:1903578 |
17 |
0.711
|
|
|
|
sequestering of calcium ion
|
GO:0051208 |
18 |
0.695
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.672
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.669
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.643
|
|
|
|
regulation of heart rate
|
GO:0002027 |
36 |
0.639
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.639
|
|
|
|
muscle fiber development
|
GO:0048747 |
76 |
0.638
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.633
|
|
|
|
myotube cell development
|
GO:0014904 |
60 |
0.632
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.617
|
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.602
|
|
|
|
skeletal muscle thin filament assembly
|
GO:0030240 |
2 |
0.600
|
|
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.595
|
|
|
|
skeletal myofibril assembly
|
GO:0014866 |
4 |
0.589
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.586
|
|
|
|
heart process
|
GO:0003015 |
94 |
0.585
|
|
|
|
negative regulation of potassium ion transmembrane transporter activity
|
GO:1901017 |
3 |
0.584
|
|
|
|
response to inactivity
|
GO:0014854 |
4 |
0.559
|
|
|
|
regulation of blood circulation
|
GO:1903522 |
93 |
0.553
|
|
|
|
cardiac muscle cell differentiation
|
GO:0055007 |
69 |
0.511
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.474
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.474
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.473
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.466
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.449
|
|
|
|
negative regulation of homeostatic process
|
GO:0032845 |
71 |
0.447
|
|
|
|
regulation of sarcomere organization
|
GO:0060297 |
4 |
0.443
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.440
|
|
|
|
release of sequestered calcium ion into cytosol
|
GO:0051209 |
42 |
0.437
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.434
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.434
|
|
|
|
actin mediated cell contraction
|
GO:0070252 |
15 |
0.427
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.425
|
|
|
|
regulation of ion transmembrane transport
|
GO:0034765 |
119 |
0.425
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.423
|
|
|
|
regulation of feeding behavior
|
GO:0060259 |
3 |
0.418
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
122 |
0.417
|
|
|
|
cardiac muscle fiber development
|
GO:0048739 |
4 |
0.410
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.408
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.405
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.404
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.395
|
|
|
|
cardiac muscle contraction
|
GO:0060048 |
32 |
0.386
|
|
|
|
regulation of the force of heart contraction
|
GO:0002026 |
17 |
0.383
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.381
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.381
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.378
|
|
|
|
cellular potassium ion transport
|
GO:0071804 |
43 |
0.378
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.376
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.371
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.366
|
|
|
|
regulation of ion homeostasis
|
GO:2000021 |
64 |
0.364
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.356
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.354
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.350
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.349
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.344
|
|
|
|
sequestering of metal ion
|
GO:0051238 |
19 |
0.341
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.335
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.331
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.329
|
|
|
|
regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion
|
GO:0010881 |
7 |
0.329
|
|
|
|
cardiac myofibril assembly
|
GO:0055003 |
12 |
0.328
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.326
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.325
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.325
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.324
|
|
|
|
regulation of muscle contraction
|
GO:0006937 |
49 |
0.322
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.310
|
|
|
|
regulation of actin filament based process
|
GO:0032970 |
99 |
0.309
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.301
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.297
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.295
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.288
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.287
|
|
|
|
potassium ion transmembrane transport
|
GO:0071805 |
43 |
0.286
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.284
|
|
|
|
regulation of skeletal muscle contraction by calcium ion signaling
|
GO:0014722 |
3 |
0.284
|
|
|
|
myotube differentiation involved in skeletal muscle regeneration
|
GO:0014908 |
2 |
0.269
|
|
|
|
regulation of inward rectifier potassium channel activity
|
GO:1901979 |
1 |
0.268
|
|
|
|
calcium ion transport into cytosol
|
GO:0060402 |
48 |
0.265
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.259
|
|
|
|
ventricular cardiac myofibril assembly
|
GO:0055005 |
3 |
0.258
|
|
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.258
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.256
|
|
|
|
regulation of striated muscle contraction
|
GO:0006942 |
25 |
0.251
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.248
|
|
|
|
adult behavior
|
GO:0030534 |
135 |
0.246
|
|
|
|
regulation of ion transmembrane transporter activity
|
GO:0032412 |
54 |
0.246
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.243
|
|
|
|
cardiac muscle cell contraction
|
GO:0086003 |
7 |
0.237
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.235
|
|
|
|
ribonucleoside monophosphate catabolic process
|
GO:0009158 |
57 |
0.233
|
|
|
|
regulation of skeletal muscle fiber development
|
GO:0048742 |
36 |
0.233
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.232
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.231
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.231
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.228
|
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
128 |
0.228
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.226
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.225
|
|
|
|
cardiac ventricle morphogenesis
|
GO:0003208 |
50 |
0.225
|
|
|
|
cerebellar cortex formation
|
GO:0021697 |
22 |
0.224
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.215
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.215
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.211
|
|
|
|
potassium ion transport
|
GO:0006813 |
52 |
0.211
|
|
|
|
planar cell polarity pathway involved in pericardium morphogenesis
|
GO:0061354 |
2 |
0.210
|
|
|
|
kidney rudiment formation
|
GO:0072003 |
3 |
0.208
|
|
|
|
cardiac cell development
|
GO:0055006 |
41 |
0.203
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.200
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.198
|
|
|
|
regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum
|
GO:0010880 |
10 |
0.198
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.198
|
|
|
|
ventricular cardiac muscle cell action potential
|
GO:0086005 |
4 |
0.194
|
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.194
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.192
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.182
|
|
|
|
cardiac muscle tissue morphogenesis
|
GO:0055008 |
44 |
0.181
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.180
|
|
|
|
planar cell polarity pathway involved in ventricular septum morphogenesis
|
GO:0061348 |
2 |
0.178
|
|
|
|
regulation of atpase activity
|
GO:0043462 |
9 |
0.177
|
|
|
|
lateral sprouting involved in mammary gland duct morphogenesis
|
GO:0060599 |
2 |
0.177
|
|
|
|
purine nucleoside monophosphate catabolic process
|
GO:0009128 |
58 |
0.176
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.173
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.171
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.170
|
|
|
|
response to starvation
|
GO:0042594 |
65 |
0.168
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.161
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.160
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.160
|
|
|
|
calcium ion transport from endoplasmic reticulum to cytosol
|
GO:1903514 |
12 |
0.158
|
|
|
|
muscle filament sliding
|
GO:0030049 |
1 |
0.157
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.156
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.156
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.154
|
|
|
|
somite development
|
GO:0061053 |
81 |
0.154
|
|
|
|
regulation of actin cytoskeleton organization
|
GO:0032956 |
84 |
0.154
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.152
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.152
|
|
|
|
purine ribonucleoside monophosphate metabolic process
|
GO:0009167 |
80 |
0.149
|
|
|
|
mitral valve morphogenesis
|
GO:0003183 |
4 |
0.148
|
|
|
|
myoblast differentiation
|
GO:0045445 |
52 |
0.146
|
|
|
|
muscle tissue morphogenesis
|
GO:0060415 |
53 |
0.144
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.142
|
|
|
|
uterus morphogenesis
|
GO:0061038 |
2 |
0.142
|
|
|
|
membrane depolarization during sa node cell action potential
|
GO:0086046 |
2 |
0.140
|
|
|
|
cardiac conduction
|
GO:0061337 |
17 |
0.135
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.135
|
|
|
|
protein oligomerization
|
GO:0051259 |
67 |
0.135
|
|
|
|
morphogenesis of a polarized epithelium
|
GO:0001738 |
37 |
0.135
|
|
|
|
t cell proliferation
|
GO:0042098 |
120 |
0.134
|
|
|
|
negative regulation of potassium ion transmembrane transport
|
GO:1901380 |
4 |
0.134
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.132
|
|
|
|
sa node cell to atrial cardiac muscle cell signalling
|
GO:0086018 |
4 |
0.132
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.130
|
|
|
|
positive regulation of pinocytosis
|
GO:0048549 |
1 |
0.129
|
|
|
|
cell matrix adhesion
|
GO:0007160 |
68 |
0.129
|
|
|
|
axis elongation involved in somitogenesis
|
GO:0090245 |
4 |
0.129
|
|
|
|
skeletal muscle myosin thick filament assembly
|
GO:0030241 |
1 |
0.128
|
|
|
|
thyroid stimulating hormone secreting cell differentiation
|
GO:0060129 |
4 |
0.127
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.127
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.123
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.122
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.121
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.121
|
|
|
|
atp metabolic process
|
GO:0046034 |
75 |
0.118
|
|
|
|
cellular modified amino acid biosynthetic process
|
GO:0042398 |
12 |
0.117
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.117
|
|
|
|
regulation of transporter activity
|
GO:0032409 |
57 |
0.116
|
|
|
|
cell cell signaling involved in lung development
|
GO:0060495 |
1 |
0.116
|
|
|
|
regulation of potassium ion transmembrane transporter activity
|
GO:1901016 |
7 |
0.115
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.115
|
|
|
|
trachea cartilage morphogenesis
|
GO:0060535 |
4 |
0.115
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.114
|
|
|
|
nucleoside monophosphate catabolic process
|
GO:0009125 |
59 |
0.113
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.113
|
|
|
|
regulation of myotube differentiation
|
GO:0010830 |
62 |
0.111
|
|
|
|
potassium ion homeostasis
|
GO:0055075 |
4 |
0.109
|
|
|
|
segmentation
|
GO:0035282 |
93 |
0.109
|
|
|
|
regulation of cardiac muscle contraction
|
GO:0055117 |
21 |
0.108
|
|
|
|
response to metal ion
|
GO:0010038 |
47 |
0.107
|
|
|
|
positive regulation of nucleoside metabolic process
|
GO:0045979 |
91 |
0.106
|
|
|
|
cardiac right atrium morphogenesis
|
GO:0003213 |
3 |
0.105
|
|
|
|
feeding behavior
|
GO:0007631 |
62 |
0.103
|
|
|
|
regulation of fibroblast growth factor production
|
GO:0090270 |
4 |
0.102
|
|
|
|
regulation of g protein activated inward rectifier potassium channel activity
|
GO:1900128 |
1 |
0.102
|
|
|
|
calcium ion transmembrane transport
|
GO:0070588 |
85 |
0.101
|
|
|
|
cytosolic calcium ion transport
|
GO:0060401 |
48 |
0.101
|
|
|
|
atrial cardiac muscle tissue development
|
GO:0003228 |
5 |
0.101
|
|
|
|
midbrain hindbrain boundary maturation during brain development
|
GO:0022004 |
1 |
0.100
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.099
|
|
|
|
regulation of potassium ion transmembrane transport
|
GO:1901379 |
11 |
0.098
|
|
|
|
cellular modified amino acid metabolic process
|
GO:0006575 |
63 |
0.098
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.098
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.096
|
|
|
|
lung induction
|
GO:0060492 |
3 |
0.096
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.095
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.095
|
|
|
|
fatty acid metabolic process
|
GO:0006631 |
121 |
0.095
|
|
|
|
cell proliferation in hindbrain
|
GO:0021534 |
10 |
0.094
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.094
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.093
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.092
|
|
|
|
neural tube formation
|
GO:0001841 |
108 |
0.092
|
|
|
|
bmp signaling pathway
|
GO:0030509 |
93 |
0.091
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.091
|
|
|
|
muscle cell fate specification
|
GO:0042694 |
1 |
0.091
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.090
|
|
|
|
atp catabolic process
|
GO:0006200 |
55 |
0.090
|
|
|
|
somitogenesis
|
GO:0001756 |
69 |
0.090
|
|
|
|
paramesonephric duct development
|
GO:0061205 |
3 |
0.088
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.088
|
|
|
|
negative regulation of epithelial cell proliferation
|
GO:0050680 |
64 |
0.088
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.088
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.088
|
|
|
|
spemann organizer formation
|
GO:0060061 |
2 |
0.086
|
|
|
|
mitochondrion organization
|
GO:0007005 |
134 |
0.086
|
|
|
|
nucleoside monophosphate metabolic process
|
GO:0009123 |
85 |
0.085
|
|
|
|
regulation of neurotransmitter levels
|
GO:0001505 |
87 |
0.085
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.085
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.084
|
|
|
|
lipid storage
|
GO:0019915 |
36 |
0.083
|
|
|
|
regulation of retina development in camera type eye
|
GO:1902866 |
3 |
0.083
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.083
|
|
|
|
striated muscle atrophy
|
GO:0014891 |
2 |
0.082
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.082
|
|
|
|
mesonephric tubule formation
|
GO:0072172 |
11 |
0.080
|
|
|
|
regulation of anagen
|
GO:0051884 |
1 |
0.080
|
|
|
|
central nervous system morphogenesis
|
GO:0021551 |
2 |
0.079
|
|
|
|
ribonucleoside monophosphate metabolic process
|
GO:0009161 |
80 |
0.079
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.078
|
|
|
|
lymphocyte activation involved in immune response
|
GO:0002285 |
93 |
0.078
|
|
|
|
purine ribonucleoside monophosphate catabolic process
|
GO:0009169 |
57 |
0.078
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.078
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.078
|
|
|
|
oxygen homeostasis
|
GO:0032364 |
2 |
0.078
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.077
|
|
|
|
mating behavior sex discrimination
|
GO:0048047 |
1 |
0.077
|
|
|
|
l glutamate import into cell
|
GO:1990123 |
3 |
0.077
|
|
|
|
syncytium formation
|
GO:0006949 |
43 |
0.077
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.076
|
|
|
|
positive regulation of potassium ion transmembrane transport
|
GO:1901381 |
3 |
0.076
|
|
|
|
nephric duct formation
|
GO:0072179 |
4 |
0.075
|
|
|
|
positive regulation of potassium ion transport
|
GO:0043268 |
3 |
0.075
|
|
|
|
central nervous system vasculogenesis
|
GO:0022009 |
3 |
0.074
|
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.074
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.074
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.074
|
|
|
|
renal sodium ion transport
|
GO:0003096 |
2 |
0.074
|
|
|
|
negative regulation of potassium ion transport
|
GO:0043267 |
7 |
0.073
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.072
|
|
|
|
membrane repolarization
|
GO:0086009 |
7 |
0.071
|
|
|
|
positive regulation of nucleotide catabolic process
|
GO:0030813 |
88 |
0.071
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.071
|
|
|
|
extraocular skeletal muscle development
|
GO:0002074 |
2 |
0.070
|
|
|
|
cellular glucan metabolic process
|
GO:0006073 |
32 |
0.070
|
|
|
|
regulation of cell substrate adhesion
|
GO:0010810 |
73 |
0.069
|
|
|
|
regulation of endocardial cushion to mesenchymal transition involved in heart valve formation
|
GO:2000800 |
1 |
0.069
|
|
|
|
positive regulation of glial cell proliferation
|
GO:0060252 |
4 |
0.069
|
|
|
|
positive regulation of atpase activity
|
GO:0032781 |
3 |
0.067
|
|
|
|
cd4 positive alpha beta t cell differentiation involved in immune response
|
GO:0002294 |
28 |
0.067
|
|
|
|
tube closure
|
GO:0060606 |
91 |
0.067
|
|
|
|
positive regulation of cytosolic calcium ion concentration
|
GO:0007204 |
65 |
0.067
|
|
|
|
skeletal muscle cell differentiation
|
GO:0035914 |
66 |
0.067
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.066
|
|
|
|
regulation of lipid storage
|
GO:0010883 |
20 |
0.066
|
|
|
|
positive regulation of myoblast differentiation
|
GO:0045663 |
8 |
0.065
|
|
|
|
energy derivation by oxidation of organic compounds
|
GO:0015980 |
77 |
0.065
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.065
|
|
|
|
response to muscle inactivity involved in regulation of muscle adaptation
|
GO:0014877 |
4 |
0.064
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.064
|
|
|
|
mitral valve development
|
GO:0003174 |
4 |
0.064
|
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.063
|
|
|
|
regulation of myoblast differentiation
|
GO:0045661 |
29 |
0.063
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.063
|
|
|
|
response to denervation involved in regulation of muscle adaptation
|
GO:0014894 |
4 |
0.063
|
|
|
|
cardiac muscle hypertrophy in response to stress
|
GO:0014898 |
10 |
0.062
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.062
|
|
|
|
response to muscle inactivity
|
GO:0014870 |
4 |
0.062
|
|
|
|
regulation of relaxation of muscle
|
GO:1901077 |
8 |
0.062
|
|
|
|
gas homeostasis
|
GO:0033483 |
3 |
0.061
|
|
|
|
positive regulation of purine nucleotide catabolic process
|
GO:0033123 |
88 |
0.061
|
|
|
|
amino acid uptake involved in synaptic transmission
|
GO:0051933 |
3 |
0.060
|
|
|
|
l glutamate uptake involved in synaptic transmission
|
GO:0051935 |
3 |
0.059
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.059
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
87 |
0.059
|
|
|
|
tissue regeneration
|
GO:0042246 |
22 |
0.059
|
|
|
|
neural tube closure
|
GO:0001843 |
90 |
0.059
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.058
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.058
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.058
|
|
|
|
cervix development
|
GO:0060067 |
2 |
0.058
|
|
|
|
regulation of cardiac muscle cell proliferation
|
GO:0060043 |
23 |
0.058
|
|
|
|
response to activity
|
GO:0014823 |
13 |
0.057
|
|
|
|
positive regulation of branching involved in ureteric bud morphogenesis
|
GO:0090190 |
18 |
0.057
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.057
|
|
|
|
hair follicle morphogenesis
|
GO:0031069 |
29 |
0.056
|
|
|
|
somatotropin secreting cell differentiation
|
GO:0060126 |
4 |
0.056
|
|
|
|
inner medullary collecting duct development
|
GO:0072061 |
2 |
0.056
|
|
|
|
regulation of membrane repolarization
|
GO:0060306 |
7 |
0.056
|
|
|
|
response to alcohol
|
GO:0097305 |
48 |
0.056
|
|
|
|
establishment of planar polarity
|
GO:0001736 |
28 |
0.055
|
|
|
|
positive regulation of cellular ph reduction
|
GO:0032849 |
2 |
0.055
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.055
|
|
|
|
regulation of canonical wnt signaling pathway involved in controlling type b pancreatic cell proliferation
|
GO:2000079 |
1 |
0.055
|
|
|
|
regulation of rna polymerase ii transcriptional preinitiation complex assembly
|
GO:0045898 |
2 |
0.055
|
|
|
|
neurotransmitter transport
|
GO:0006836 |
76 |
0.054
|
|
|
|
establishment of planar polarity involved in neural tube closure
|
GO:0090177 |
15 |
0.054
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.054
|
|
|
|
regulation of potassium ion transport
|
GO:0043266 |
16 |
0.054
|
|
|
|
planar cell polarity pathway involved in cardiac muscle tissue morphogenesis
|
GO:0061350 |
2 |
0.054
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.053
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.053
|
|
|
|
sodium ion transmembrane transport
|
GO:0035725 |
49 |
0.053
|
|
|
|
oligopeptide transmembrane transport
|
GO:0035672 |
4 |
0.053
|
|
|
|
axonal fasciculation
|
GO:0007413 |
15 |
0.053
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.053
|
|
|
|
regulation of ureteric bud formation
|
GO:0072106 |
3 |
0.052
|
|
|
|
cerebellum formation
|
GO:0021588 |
1 |
0.052
|
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.051
|
|
|
|
positive regulation of ureteric bud formation
|
GO:0072107 |
3 |
0.051
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.051
|
|
|
|
axon guidance
|
GO:0007411 |
141 |
0.051
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.051
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.051
|
|
|
|
histone modification
|
GO:0016570 |
159 |
0.051
|
|
|
|
tight junction assembly
|
GO:0070830 |
9 |
0.051
|
|
|
|
regulation of white fat cell proliferation
|
GO:0070350 |
2 |
0.050
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.050
|
|
|
|
cytosolic calcium ion homeostasis
|
GO:0051480 |
70 |
0.050
|
|
|
|
spermatid development
|
GO:0007286 |
108 |
0.050
|
|
|
|
skeletal muscle fiber adaptation
|
GO:0043503 |
1 |
0.050
|
|
|
|
primary neural tube formation
|
GO:0014020 |
95 |
0.050
|
|
|
|
purine nucleoside monophosphate metabolic process
|
GO:0009126 |
81 |
0.049
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.049
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.049
|
|
|
|
sa node cell action potential
|
GO:0086015 |
4 |
0.049
|
|
|
|
gene silencing
|
GO:0016458 |
38 |
0.048
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.047
|
|
|
|
semicircular canal formation
|
GO:0060876 |
1 |
0.047
|
|
|
|
tubulin complex assembly
|
GO:0007021 |
2 |
0.047
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.047
|
|
|
|
ventricular cardiac muscle tissue development
|
GO:0003229 |
38 |
0.047
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.047
|
|
|
|
multicellular organismal movement
|
GO:0050879 |
16 |
0.046
|
|
|
|
t helper cell differentiation
|
GO:0042093 |
28 |
0.046
|
|
|
|
renal outer medulla development
|
GO:0072054 |
2 |
0.046
|
|
|
|
cellular amino acid biosynthetic process
|
GO:0008652 |
22 |
0.045
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.045
|
|
|
|
positive regulation of cardiac muscle tissue growth
|
GO:0055023 |
15 |
0.045
|
|
|
|
regulation of circadian sleep wake cycle
|
GO:0042749 |
3 |
0.045
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.045
|
|
|
|
cardiac ventricle development
|
GO:0003231 |
83 |
0.045
|
|
|
|
negative regulation of organelle organization
|
GO:0010639 |
90 |
0.045
|
|
|
|
negative regulation of wnt signaling pathway
|
GO:0030178 |
73 |
0.045
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.044
|
|
|
|
regulation of long term neuronal synaptic plasticity
|
GO:0048169 |
19 |
0.044
|
|
|
|
cardiac atrium development
|
GO:0003230 |
24 |
0.044
|
|
|
|
muscle cell proliferation
|
GO:0033002 |
52 |
0.044
|
|
|
|
sensory perception of pain
|
GO:0019233 |
47 |
0.044
|
|
|
|
regulation of satellite cell proliferation
|
GO:0014842 |
5 |
0.044
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.043
|
|
|
|
regulation of establishment of planar polarity
|
GO:0090175 |
28 |
0.043
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.043
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.043
|
|
|
|
outer medullary collecting duct development
|
GO:0072060 |
1 |
0.042
|
|
|
|
regulation of transforming growth factor beta2 production
|
GO:0032909 |
2 |
0.042
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.042
|
|
|
|
musculoskeletal movement
|
GO:0050881 |
16 |
0.042
|
|
|
|
response to steroid hormone
|
GO:0048545 |
56 |
0.042
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.042
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.041
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.041
|
|
|
|
regulation of calcium ion transport into cytosol
|
GO:0010522 |
31 |
0.041
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.041
|
|
|
|
response to muscle stretch
|
GO:0035994 |
1 |
0.041
|
|
|
|
hindlimb morphogenesis
|
GO:0035137 |
42 |
0.041
|
|
|
|
renal inner medulla development
|
GO:0072053 |
3 |
0.041
|
|
|
|
tubulin complex biogenesis
|
GO:0072668 |
2 |
0.041
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.041
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.041
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.040
|
|
|
|
regulation of circadian sleep wake cycle sleep
|
GO:0045187 |
3 |
0.040
|
|
|
|
positive regulation of high voltage gated calcium channel activity
|
GO:1901843 |
1 |
0.040
|
|
|
|
microglial cell activation
|
GO:0001774 |
3 |
0.040
|
|
|
|
eating behavior
|
GO:0042755 |
15 |
0.040
|
|
|
|
tertiary branching involved in mammary gland duct morphogenesis
|
GO:0060748 |
3 |
0.040
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.040
|
|
|
|
heart growth
|
GO:0060419 |
45 |
0.040
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.040
|
|
|
|
regulation of cardiac muscle tissue development
|
GO:0055024 |
31 |
0.039
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
144 |
0.039
|
|
|
|
membrane lipid biosynthetic process
|
GO:0046467 |
32 |
0.039
|
|
|
|
cellular response to steroid hormone stimulus
|
GO:0071383 |
33 |
0.039
|
|
|
|
establishment of endothelial blood brain barrier
|
GO:0014045 |
3 |
0.039
|
|
|
|
regulation of embryonic development
|
GO:0045995 |
71 |
0.038
|
|
|
|
ventricular cardiac muscle tissue morphogenesis
|
GO:0055010 |
32 |
0.038
|
|
|
|
cerebellar granule cell precursor proliferation
|
GO:0021930 |
10 |
0.038
|
|
|
|
monosaccharide metabolic process
|
GO:0005996 |
106 |
0.038
|
|
|
|
regulation of skeletal muscle cell proliferation
|
GO:0014857 |
7 |
0.038
|
|
|
|
negative regulation of bone trabecula formation
|
GO:1900155 |
1 |
0.038
|
|
|
|
regulation of calcium ion transport
|
GO:0051924 |
69 |
0.038
|
|
|
|
negative regulation of transmembrane transport
|
GO:0034763 |
15 |
0.038
|
|
|
|
submandibular salivary gland formation
|
GO:0060661 |
1 |
0.038
|
|
|
|
regulation of metal ion transport
|
GO:0010959 |
106 |
0.038
|
|
|
|
tongue development
|
GO:0043586 |
18 |
0.038
|
|
|
|
forelimb morphogenesis
|
GO:0035136 |
40 |
0.037
|
|
|
|
glucose metabolic process
|
GO:0006006 |
92 |
0.037
|
|
|
|
regulation of extrinsic apoptotic signaling pathway
|
GO:2001236 |
77 |
0.037
|
|
|
|
potassium ion import
|
GO:0010107 |
1 |
0.037
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.037
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.037
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.037
|
|
|
|
regulation of microtubule cytoskeleton organization
|
GO:0070507 |
37 |
0.037
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.037
|
|
|
|
positive regulation of cell growth
|
GO:0030307 |
33 |
0.037
|
|
|
|
embryonic hindlimb morphogenesis
|
GO:0035116 |
32 |
0.037
|
|
|
|
regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043281 |
62 |
0.037
|
|
|
|
canonical wnt signaling pathway involved in heart development
|
GO:0061316 |
3 |
0.036
|
|
|
|
intrinsic apoptotic signaling pathway in response to osmotic stress
|
GO:0008627 |
2 |
0.036
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.036
|
|
|
|
dephosphorylation
|
GO:0016311 |
129 |
0.036
|
|
|
|
lipid modification
|
GO:0030258 |
65 |
0.036
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.036
|
|
|
|
t cell differentiation involved in immune response
|
GO:0002292 |
30 |
0.036
|
|
|
|
endodermal cell fate specification
|
GO:0001714 |
4 |
0.036
|
|
|
|
cell differentiation in hindbrain
|
GO:0021533 |
24 |
0.036
|
|
|
|
regulation of heart growth
|
GO:0060420 |
31 |
0.036
|
|
|
|
establishment of planar polarity involved in nephron morphogenesis
|
GO:0072046 |
1 |
0.035
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.035
|
|
|
|
regulation of calcium ion transmembrane transporter activity
|
GO:1901019 |
20 |
0.035
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.035
|
|
|
|
negative regulation of mesenchymal cell proliferation
|
GO:0072201 |
3 |
0.035
|
|
|
|
negative regulation of prostatic bud formation
|
GO:0060686 |
4 |
0.035
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
88 |
0.035
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.034
|
|
|
|
positive regulation of striated muscle tissue development
|
GO:0045844 |
31 |
0.034
|
|
|
|
regulation of striated muscle cell differentiation
|
GO:0051153 |
81 |
0.034
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.034
|
|
|
|
syncytium formation by plasma membrane fusion
|
GO:0000768 |
42 |
0.034
|
|
|
|
molting cycle
|
GO:0042303 |
90 |
0.034
|
|
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.034
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.034
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.034
|
|
|
|
positive regulation of endocardial cushion to mesenchymal transition involved in heart valve formation
|
GO:2000802 |
1 |
0.034
|
|
|
|
negative regulation of binding
|
GO:0051100 |
39 |
0.034
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.034
|
|